Skip to Main Content
Welcome to the Marketplace

Go to Main Navigation

SPR-406B SPR-405B SPR-406C SPR-405C +2

Beta Synuclein Monomers

Stressmarq Biosciences


Human Recombinant Beta Synuclein Protein Monomers


  • Nature: Recombinant
  • Purity: >95%
  • Target: Beta Synuclein
  • Category: Protein
  • Conjugate: No tag
  • References: 1. 2. Alzheimer, A. Über eine eigenartige Erkrankung der Hirnrinde. Allg. Z. Psychiatr. Psych.-Gerichtl. Med. 64, 146–148 (1907). 3. Taschenberger G., et al. (2013) Ann Neurol. 74(1): 109-118.
  • Applications: WB | SDS-PAGE | In vivo assay | In vitro assay
  • Field of Use: Not for use in humans. Not for use in diagnostics or therapeutics. For research use only.
  • Protein Size: 14.28 kDa
  • Purification: Ion-exchange Purified
  • Concentration: Lot/batch specific. See included datasheet.
  • Protein Length: Full length
  • Research Areas: Neuroscience | Neurodegeneration | Alzheimer's Disease | Tangles & Tau | Neuroscience | Neurodegeneration | Parkinson's Disease | Synuclein
  • Storage Buffer: PBS pH 7.4
  • Alternative Names: 14 kDa brain-specific protein, Beta-synuclein Protein, Phosphoneuroprotein 14 Protein, PNP14 Protein, Sncb Protein, Synuclein beta Protein, SYUB_HUMAN Protein
  • Cite This Product: Human Recombinant Beta Synuclein Protein (StressMarq Biosciences Inc., Victoria BC CANADA, Catalog # SPR-405B)
  • Expression System: E. coli
  • Species Full Name: Human
  • Storage Temperature: -80ºC
  • Shipping Temperature: Dry Ice. Shipping note: Product will be shipped separately from other products purchased in the same order.
  • Cellular Localization: Cytoplasm
  • Scientific Background: Alzheimer’s Disease (AD) is the most common neurodegenerative disease, affecting 10% of seniors over the age of 65 (1). It was named after Alois Alzheimer, a German scientist who discovered tangled bundles of fibrils where neurons had once been in the brain of a deceased patient in 1907 (2). Beta synuclein is abundant in neurofibrillary lesions of patients with Alzheimer's Disease. Beta synuclein is suggested to be an inhibitor of alpha synuclein aggregation- protecting the central nervous system from the neurotoxin effects of alpha synuclein (3).
  • Certificate of Analysis: Certified >95% pure using SDS-PAGE analysis.